Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
autoimmune disease
Biotech
New cancer cases prompt Kyowa to shutter rocatinlimab trials
Kyowa had originally planned to seek FDA approval of the asset in atopic dermatitis in the first half of this year.
Gabrielle Masson
Mar 3, 2026 11:00am
After R&D head exits, Immunocore CEO pairs ambition with caution
Feb 13, 2026 12:44pm
Priovant will move brepocitinib to phase 3 after midstage win
Feb 6, 2026 7:00am
Lilly drops 3 clinical programs, including Prevail gene therapy
Feb 4, 2026 12:33pm
Amgen exits $400M autoimmune pact after running vast program
Jan 30, 2026 8:55am
AI-driven Formation snaps up oral autoimmune asset in $500M play
Jan 29, 2026 1:20pm
